Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
05.12.24 | On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin | ||
05.12.24 | Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal | ||
05.12.24 | AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer | ||
05.12.24 | GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal | ||
05.12.24 | Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed | ||
05.12.24 | AstraZeneca chided by marketing watchdog after complainant aims allegations at senior staff | ||
05.12.24 | For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access | ||
05.12.24 | FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri after brief delay | ||
04.12.24 | Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark | ||
04.12.24 | AstraZeneca's Enhertu and Akeso's bispecifics win national coverage in China as CAR-T therapies miss out again | ||
04.12.24 | Klick Health uses AI to orchestrate 'Holiday Hugs' after survey shows scarcity in year-round embraces | ||
04.12.24 | With AstraZeneca exec under investigation in China, company names Reic new international chief | ||
04.12.24 | Sumitomo brings together Gemtesa 'Go-Getters' to discuss overactive bladder symptoms | ||
04.12.24 | Novavax scores $200M as it hands over keys to Czech production plant-along with 300 employees-to Novo Nordisk | ||
04.12.24 | Eli Lilly's Zepbound defeats Novo Nordisk's Wegovy in head-to-head weight loss trial | ||
03.12.24 | Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds | ||
03.12.24 | IRA price negotiations and M&A among topics to watch after 'Republican Red Wave,' analyst group says | ||
03.12.24 | CSL Seqirus inks bird flu vaccine supply pact with UK after similar deals in US, Europe | ||
03.12.24 | Reckitt shells out $200M to expand its Mucinex production site in North Carolina | ||
03.12.24 | Lil Jon delivers scat rap, duets with singing toilet to promote Exact Sciences' cancer kit | ||
03.12.24 | Agenus to offer CDMO services as part of its latest reorganization | ||
03.12.24 | RFK Jr. could 'cost lives in this country' if he pursues changes to US vaccine policy, Gottlieb says | ||
02.12.24 | After temporary reprieve, Advanz Pharma's liver med Ocaliva loses marketing nod in Europe | ||
02.12.24 | Quantoom, Univercells and Fiocruz ink collaboration to bolster RNA-based vaccines in Brazil and beyond | ||
02.12.24 | FDA considers 'regulatory action' for bluebird's Skysona after blood cancer reports |